These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 15904510)

  • 41. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
    Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
    J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
    Shenep JL; Flynn PM; Baker DK; Hetherington SV; Hudson MM; Hughes WT; Patrick CC; Roberson PK; Sandlund JT; Santana VM; Sixbey JW; Slobod KS
    Clin Infect Dis; 2001 Jan; 32(1):36-43. PubMed ID: 11112678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current approaches for risk stratification of infectious complications in pediatric oncology.
    Härtel C; Deuster M; Lehrnbecher T; Schultz C
    Pediatr Blood Cancer; 2007 Nov; 49(6):767-73. PubMed ID: 17514729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients.
    Erbey F; Bayram I; Yilmaz S; Tanyeli A
    Asian Pac J Cancer Prev; 2010; 11(1):123-6. PubMed ID: 20593941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
    Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
    Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia?
    Oguz A; Karadeniz C; Ckitak EC; Cil V
    Pediatr Hematol Oncol; 2006 Mar; 23(2):143-51. PubMed ID: 16651243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
    Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
    Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department.
    Volpe D; Harrison S; Damian F; Rachh P; Kahlon PS; Morrissey L; Mack J; Akenroye A; Stack AM
    Pediatrics; 2012 Jul; 130(1):e201-10. PubMed ID: 22711718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of meropenem as an empirical treatment for febrile neutropenia in children with cancer.
    Pancharoen C; Mekmullica J; Buranachonapa J; Trongjit D; Nuchprayoon I; Vanichsetakul P; Seksarn P; Thisyakorn U
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S174-8. PubMed ID: 12929986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile].
    Rabagliati B R; Fuentes L G; Orellana U E; Oporto C J; Domínguez M I; Benítez G R; Aedo C I; Ramos G G; Garrido S M; García C P
    Rev Chilena Infectol; 2009 Apr; 26(2):106-13. PubMed ID: 19621141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective audit of treatment of paediatric febrile neutropenia in Australasia.
    Chamberlain JD; Smibert E; Skeen J; Alvaro F
    J Paediatr Child Health; 2005 Nov; 41(11):598-603. PubMed ID: 16398846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].
    Santolaya ME
    Rev Med Chil; 2001 Dec; 129(12):1449-54. PubMed ID: 12080883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia.
    Petrilli A; Altruda Carlesse F; Alberto Pires Pereira C
    Pediatr Blood Cancer; 2007 Oct; 49(5):682-6. PubMed ID: 17253640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
    González M; Clavell LA
    P R Health Sci J; 1987 Apr; 6(1):13-5. PubMed ID: 3615796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
    Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
    Ammann RA; Simon A; de Bont ES
    Pediatr Blood Cancer; 2005 Sep; 45(3):244-7. PubMed ID: 15747334
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.